Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
abrdn Healthcare InvestorsHQH +0.48%49 5-Year Yield-on-Cost % is 11.79 as of Aug. 07, 2026, which is 5% above its 10-year median of 11.25. GuruFocus rates HQH with a GF Score™ of 49/100 and a GF Value™ of $50.26 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,110 Asset Management companies, abrdn Healthcare Investors ranks better than 81.17% on this metric.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
abrdn Healthcare Investors 5-Year Yield-on-Cost % Related Terms
HQH vs JFR, DSL, MSDL: 5-Year Yield-on-Cost % Comparison
For the Asset Management subindustry, abrdn Healthcare Investors's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Healthcare Investors 5-Year Yield-on-Cost % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where abrdn Healthcare Investors's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
abrdn Healthcare Investors (HQH) has a 5-Year Yield-on-Cost % of 11.79 as of Aug. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on abrdn Healthcare Investors and its competitors. This is near median its historical median of 11.25. Over the past decade, abrdn Healthcare Investors' 5-Year Yield-on-Cost % has ranged from 7.69 to 15.99. According to the industry distribution chart, abrdn Healthcare Investors ranks #209 out of 1110 companies in the Asset Management industry, placing it in the top 18.8%.
Is abrdn Healthcare Investors' 5-Year Yield-on-Cost % too high?
abrdn Healthcare Investors' current 5-Year Yield-on-Cost % of 11.79 is near median its 10-year median of 11.25. Over the past 10 years, this metric has ranged from a low of 7.69 to a high of 15.99. The Asset Management industry median 5-Year Yield-on-Cost % is 6.44. abrdn Healthcare Investors' value of 11.79 is 83.1% above this industry median. Based on the distribution chart, abrdn Healthcare Investors ranks #209 out of 1110 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, abrdn Healthcare Investors has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' 5-Year Yield-on-Cost % compare to JFR and DSL?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #209 out of 1110 companies for 5-Year Yield-on-Cost %. This places abrdn Healthcare Investors in the top 19% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 6.44. abrdn Healthcare Investors' value of 11.79 is 83.1% above this benchmark. Historically, abrdn Healthcare Investors' own 5-Year Yield-on-Cost % has ranged from 7.69 to 15.99 over the past decade. While the company's 10-year median is 11.25 vs. the industry median of 6.44, abrdn Healthcare Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Asset Management company?
The median 5-Year Yield-on-Cost % among Asset Management companies is 6.44, based on 1,110 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Healthcare Investors's current 5-Year Yield-on-Cost % of 11.79 is 83.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on abrdn Healthcare Investors and its competitors. For the Asset Management industry, the median 5-Year Yield-on-Cost % is 6.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Healthcare Investors's current 5-Year Yield-on-Cost % is 11.79, which is near median its own 10-year median of 11.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $22.94 — trading 54.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 11.79, which is near median its 10-year median of 11.25 and 83.1% above the Asset Management industry median of 6.44. abrdn Healthcare Investors' overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current 5-Year Yield-on-Cost % is 11.79 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Healthcare Investors (HQH) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued.
The current stock price of $22.94 is trading 54.4% below its estimated GF Value™ of $50.26.
GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.
Key valuation signals for HQH:
5-Year Yield-on-Cost %: 11.79 (near median its 10-year median of 11.25)
GF Value™: $50.26 vs. price of $22.94 (54.4% below fair value)
Industry Position: 83.1% above the Asset Management median (#209 of 1110)
No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
49GF Score
Get the complete analysis for HQH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQH has been successfully added to your 
